ArticleCureus2025
A Case Series on Beta Thalassemia Major With Secondary Diabetes Mellitus Due to Iron Overload and Other Complications.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beta thalassemia major is an inherited hemoglobinopathy characterized by chronic hemolysis that requires lifelong blood transfusion therapy. With globalization and population migration, it has become a worldwide health concern. Inadequate transfusion therapy can result in complications such as stunted growth, jaundice, hepatosplenomegaly, bone deformities, and extramedullary hematopoiesis. Long-term transfusion treatment frequently leads to iron overload, predisposing patients to diabetes, delayed puberty, and hepatic and cardiac disorders. Additional risk factors, such as family history, lifestyle, obesity, gender, and age, may further increase susceptibility to diabetes in individuals with beta thalassemia. This case series describes three patients with β-thalassemia major complicated by secondary diabetes mellitus due to iron overload, along with variable multisystem involvement. The patients were managed through an integrated, multidisciplinary approach involving hematology, endocrinology, and cardiology, resulting in clinical stabilization and successful discharge. This case series highlights the importance of early recognition of iron overload-related complications, including secondary diabetes and associated endocrinopathies, to ensure timely intervention and optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.